Last reviewed · How we verify

NCT04214041

Autologous Fat Grafting Versus Subepithelial Connective Tissue Graft for Volume Augmentation

Completed NA Last updated 4 December 2023
What this trial tests

NA trial testing Autologous fat grafting in Alveolar Bone Loss in 20 participants. Completed in 11 September 2019.

Timeline
17 December 2018
Primary endpoint
25 June 2019
11 September 2019

Quick facts

Lead sponsorNourhan M.Aly
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment20
Start date17 December 2018
Primary completion25 June 2019
Estimated completion11 September 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Nourhan M.Aly — full company profile →

Who can join

Adults 18 to 45, any sex, with Alveolar Bone Loss. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to evaluate the effectiveness of autologous fat as a grafting material for soft tissue volume augmentation of localized horizontal ridge defects in humans.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Autologous fat grafting

Trials testing the same drug.

Other recruiting trials for Alveolar Bone Loss

Currently open trials in the same condition.

Other Nourhan M.Aly trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04214041.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing